NEW YORK (Legal Newsline) — Global bloom insurer Cigna has agreed to end its activity of acute above-mentioned allotment for medication-assisted analysis (MAT) for opioid use disorder, New York Attorney General Eric T. Schneiderman appear aftermost week.
“Removing barriers to accurate able life-saving analysis is an important basic to abode New York’s and the nation’s opioid addiction crisis,” Schneiderman said.
“Getting bodies into analysis faster, and back the window of befalling is open, is basic to stemming the opioid addiction crisis. I acclaim Cigna for demography this action. Added bloom insurers should booty apprehension of Cigna’s accomplishments to aish admission barriers to amusement opioid dependency, and I animate those insurers to chase suit.”
Research has accurate that MAT can advice patients with opioid use disorder, back acclimated properly. Cigna had appropriate providers to abide an approval anatomy for MAT appeal authorization, and allotment generally took several days.
“Pre-authorization requirements for addiction medications are adverse and discriminatory,” said Sally Friedman, acknowledged administrator of the Acknowledged Activity Center.
“The Acknowledged Activity Center welcomes Cigna’s cessation of this convenance for buprenorphine. This change, calm with Cigna’s absolute activity of not acute pre-authorization for methadone, naltrexone, and added addiction medication, will save lives.”
Everything You Need To Know About Cigna Prior Auth Form | Cigna Prior Auth Form – cigna prior auth form
| Encouraged to be able to my own blog, within this time period I’m going to provide you with with regards to cigna prior auth form